RetinalGenix Technologies (RTGN) Other Non-Current Liabilities (2022 - 2026)
RetinalGenix Technologies (RTGN) posted Other Non-Current Liabilities of $831000.0 for Q1 2026, up 69.86% sequentially from $489224.0 in Q4 2025, and up 63.99% YoY from $506748.0 in Q1 2025.
RetinalGenix Technologies (RTGN) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
RetinalGenix Technologies has reported Other Non-Current Liabilities for 5 years, with the latest figure at $831000.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 63.99% year-over-year to $831000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $831000.0 (up 63.99% YoY) and the FY2025 annual result came in at $489224.0, up 4.58% from the prior year.
- Other Non-Current Liabilities improved to $831000.0 in Q1 2026 per RTGN's latest filing, from $489224.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $831000.0 in Q1 2026 and troughed at $900.0 in Q3 2023.
- A 5-year average of $425499.0 and a median of $477126.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- The widest YoY moves for Other Non-Current Liabilities: up 52914.0% in 2024, down 33.05% in 2024.
- Over 5 years, Other Non-Current Liabilities stood at $109185.0 in 2022, then jumped by 319.04% to $457534.0 in 2023, then rose by 2.24% to $467793.0 in 2024, then increased by 4.58% to $489224.0 in 2025, then soared by 69.86% to $831000.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $831000.0, $489224.0, and $539000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 831,000.00 |
| Dec 31, 2025 | 489,224.00 |
| Sep 30, 2025 | 539,000.00 |
| Jun 30, 2025 | 547,148.00 |
| Mar 31, 2025 | 506,748.00 |
| Dec 31, 2024 | 467,793.00 |
| Sep 30, 2024 | 477,126.00 |
| Jun 30, 2024 | 543,061.00 |
| Mar 31, 2024 | 193,000.00 |
| Dec 31, 2023 | 457,534.00 |
| Sep 30, 2023 | 900.00 |
| Jun 30, 2023 | 811,176.00 |
| Mar 31, 2023 | 194,192.00 |
| Dec 31, 2022 | 109,185.00 |
| Jun 30, 2022 | 215,398.00 |